The tale of Lilly, Ypsomed and an automated insulin delivery (AID) system. Eli Lilly, one of the Big Three insulin makers that’s had its eyes
The US FDA has granted Fast Track Designation for VX-880, an investigational allogeneic human stem cell-derived islet cell therapy for people with Type 1 diabetes.
Researchers at Action on Salt are calling for a restriction on the use of misleading nutrition claims following new data, which reveals that some seemingly
JDRF Impact Report 2020-21 JDRF has published its latest annual report highlighting the charities achievements. The Impact Report 2019-2020 explains how the Type 1 diabetes
Across the English Channel a small but dedicated company called Diabeloop is pushing forward a closed-loop insulin delivery system. Diabeloop was founded in 2015 and
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals, diagnostics and diabetes
